Availability: In Stock

Handbook of Obesity – Volume 2 Clinical Applications 5th Edition

ISBN: 9781032551081
ISBN: 9781032551081
Διαστάσεις 28 × 21 cm



Ημ. Έκδοσης





5η έκδοση


Κύριος Συγγραφέας

175,00€(Περιλαμβάνεται ΦΠΑ 6%)

Διαθεσιμότητα: 23-28 ημέρες


Volume 2 of the 5th Edition of the Handbook of Obesity spotlights on clinical applications for evaluation, diagnosis, prevention, and treatment of obesity. It covers on the several major developments occurred between the previous and the new edition, including the effect of SARS-CoV-2 on people with obesity, the concept of “Precision Medicine”, and new medications approved by USFDA aiding patients with obesity weight loss of 15 to 20%.

This volume is structured into 5 parts:
Part 1 provides insights from evolution on changes in diet and physical activity, and the implications and results for preventing obesity, health care costs associated with obesity and the cost-effectiveness of obesity prevention and treatment.
Part 2 deals with evaluation of overweight patients, approaches for classifying obesity and using this knowledge to evaluate patients, and addressing ethnic and racial considerations in evaluating patients with obesity.
Part 3 explains the impact of lifestyle in managing obesity, which include behavioural management, diet, dietary composition, and meal timing, and the effects of physical activity and exercise in weight loss and weight loss maintenance.
Part 4 is focused on medications in the management of obesity. This includes drug selection, various classes of drugs, combination of drugs affecting weight loss, effect of herbal agents on weight loss and treatment of obesity in pediatric populations, genetic diseases causing obesity and the role of drugs in treating the dyslipidemias.
Part 5 discusses bariatric surgery, its history, procedure and effects in details, and other surgical techniques including electric stimulation of the vagus nerve, gastric balloons, intestinal liners, and liposuction.


Part 1 Prevention and Economic Outcomes of Obesity
Chapter 1 Dietary Changes in Human Evolution: Implications for the Prevention of Obesity
Peter Andrews and Richard Johnson

Chapter 2 Evolutionary Changes in Physical Activity, Diet, and Energy Expenditure: Implications for the Prevention of Obesity
Herman Pontzer

Chapter 3 Prevention of Obesity in Adults
Suzanne Phelan

Chapter 4 The Prevention of Obesity in Children and Adolescents
Tim Lobstein and Louise Baur

Chapter 5 Re-engineering the Built Environment: Progress in Schools, Worksites, Neighborhoods, and Communities
Stephanie T. Broyles and Maura M. Kepper

Chapter 6 The Economic Costs of Obesity
Adam Biener, John Cawley, and Chad Meyerhoefer

Chapter 7 Cost-effectiveness of Obesity Prevention and Treatment
Jaithri Ananthapavan, Marj Moodie, and Victoria Brown

Chapter 8 Role of Government and Non-Government Organizations in the Obesity Pandemic and Its Prevention
Simon Barquera, Mariel White, Gabriela Argumedo, Carolina Batis, and Juan Rivera-Dommarco

Chapter 9 Role of Reimbursement in the Delivery of Treatment for Obesity in Adults and Children
Chika Vera Anekwe, Veronica R. Johnson, Matthew J. Townsend, and Fatima Cody Stanford

Part 2 Evaluation of the Patients with Overweight or Obesity

Chapter 10 Classification, Evaluation, and Staging of the Patient with Obesity
Robert F. Kushner and Amanda Velazquez

Chapter 11 Indicators of Central Adiposity: A Critical Evaluation of Their Usefulness
Ian J. Neeland, Jean-Pierre Després, André C. Carpentier, and Paul Poirier

Chapter 12 Genetic Obesity Syndromes
I. Sadaf Farooqi and Stephen O’Rahilly

Chapter 13 Ethnic and Racial Considerations in the Evaluation of the Patient with Obesity
Peter T. Katzmarzyk, Sean Wharton, Fatima Cody Stanford, and Daniel G. Aaron

Part 3 Lifestyle in the Management of Obesity: Behavioral Modification, Diet, and Exercise

Chapter 14 Best Practices: Obesity and the Primary Care Providers
Christine Gallagher, Donna H. Ryan, and William Dietz

Chapter 15 In-person Behavioral Approaches for Weight Management
Jena S. Tronieri and Thomas A. Wadden

Chapter 16 Behavioral Interventions Delivered Remotely
Christoph Höchsmann and Corby K. Martin

Chapter 17 Cultural Considerations in Behavioral Therapy for Management of Obesity
Robert L. Newton, Jr., Elva Arredondo, Patricia Dionicio, and Noe C. Crespo

Chapter 18 Diet Composition and Weight Loss: Is a Calorie a Calorie?
Kevin D. Hall

Chapter 19 Circadian Rhythms and Weight Loss: Timed Food Intake
Emily N. C. Manoogian, Nikko R. Gutierrez, Erika Padilla, and Michael J. Wilkinson

Chapter 20 Comparison of Modern-Millennial Diets
Monica Dinu, Daniela Martini, Francesco Sofi, Mauro Serafini, Marisa Porrini, and Donato Angelino

Chapter 21 Dietary Energy Density and Its Contribution to Weight Control
Faris M. Zuraikat and Barbara J. Rolls

Chapter 22 Dietary Patterns as a Basis for Diet Selection
Catherine Champagne

Chapter 23 Physical Activity and Weight Loss: Volume, Intensity, and Mode
John M. Jakicic and Renee J. Rogers

Chapter 24 Modifying Sedentary Behavior for the Prevention and Treatment of Obesity
Bethany Barone Gibbs

Chapter 25 Preventing Weight Regain After Weight Loss
Stephen D. Anton and Michael G. Perri

Chapter 26 Personalized and Precision Nutrition in the Management of Obesity: Can We Tailor the Treatment to the Patient?
George Thom and Mike Lean

Part 4 Medications in the Management of Obesity

Chapter 27 Drug-associated Weight Gain and Clinical Alternatives
Barbara Ameer and Michael A. Weintraub

Chapter 28 Mechanisms of Drug Action in Obesity
M. Furkan Burak, Nawfal W. Istfan, and Caroline M. Apovian

Chapter 29 Metabolic Effects of Progressive Weight Loss
Faidon Magkos

Chapter 30 Older Drugs Used to Manage Obesity: Sympathomimetics and Orlistat
Frank L. Greenway and George A. Bray

Chapter 31 Serotonergic Drugs for Treating Obesity
Mireille J. Serlie

Chapter 32 Antidiabetic Drugs that Reduce Weight and Are Cardioprotective
Carolina M. Perdomo, Javier Escalada, and Gema Frühbeck

Chapter 33 Approved Combination Agents: Phentermine/Topiramate
W. Timothy Garvey

Chapter 34 Approved Combination Agents: Naltrexone-Bupropion
Igho J. Onakpoya and Carl J. Heneghan

Chapter 35 Drugs That Affect Body Weight: The Glucagon-like Peptide-1 Agonists
Randa Ghazal-Asswad and John P.H. Wilding

Chapter 36 Hydrogels in the Treatment of Obesity
Frank L. Greenway

Chapter 37 Dual and Triple-Action Peptides
Thinzar Min and Stephen C. Bain

Chapter 38 Antiobesity Medications on the Horizon
Sarah R. Barenbaum and Louis J. Aronne

Chapter 39 Treatments for Rare Forms of Genetic Obesity
Joan C. Han, Nandini Basuray, and Andrea M. Haqq

Chapter 40 Special Issues in Using Medications in Children & Adolescents
Jaime M. Moore, Stephen R. Daniels, and Claudia K. Fox

Chapter 41 Dietary Supplements and Weight Management
Carol J. Haggans, Rebecca B. Costello, Leila G. Saldanha, Abby G. Ershow, and William T. Cefalu

Part 5 Surgical Interventions for Obesity

Chapter 42 Historical Overview of Metabolic and Bariatric Surgery
Henry Buchwald

Chapter 43 Overview: Current Metabolic Operations and Long-term Outcomes
Robert C. Ross, Vance L. Albaugh, Ali Aminian, and Philip R. Schauer

Chapter 44 Effects of Metabolic Surgery on Type 2 Diabetes
Pia Roser, Ghassan Chamseddine, and Francesco Rubino

Chapter 45 Cardiovascular Outcomes in Metabolic Surgery
Wen Hui Tan, Tammy Kindel, Steven Nissen, and Philip R. Schauer

Chapter 46 Effect of Bariatric Surgery on Cancer
Justin C. Brown, Andrea M. Stroud, Priya A. Rajdev, and Bruce M. Wolfe

Chapter 47 Bariatric Surgery in Pediatric Patients
Sarah Ogle and Thomas Inge

Chapter 48 Other Bariatric Procedures: Nerve Stimulation, Gastric Balloons, Intestinal Liners, and Others
Cullen F. Roberts, Colston Edgerton, and Scott A. Shikora